Cyxone

Business Data, Corporate Office and Headquarter Address

About

Cyxone is Drug Discovery in Sweden that focus on cyxone AB business. Founded in 2015. They cover business area such as cyxone AB, a portfolio, drug, autoimmune disease, multiple sclerosis, (MS, arthritis, RA, Rabeximod.

Business Type

Drug Discovery

Country

Sweden

Founded

2015
( 9 years old in 2024 )

Company Focus

Cyxone AB

Website

-

Corporate Office and Headquarter Office address:

Adelgatan 21
211 22 Malmo
Sweden

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

cyxone ABa portfoliodrugautoimmune diseasemultiple sclerosis(MSarthritisRARabeximod

* We use standard office opening hours in near Cyxone's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Cyxone Frequently Asked Questions

What or who is Cyxone?

Cyxone is Drug Discovery business from Sweden that founded in 2015 (9 years old in 2024), Cyxone business is focusing on Cyxone AB.

Where is Cyxone headquarter and corporate office address?

Cyxone headquarter office and corporate office address is located in Adelgatan 21 211 22 Malmo Sweden.

Where is Cyxone country origins?

Cyxone was founded in Sweden.

What is Cyxone AB business focus on?

In 2024, Cyxone is currently focus on cyxone AB sector.

Cyxone AB Business Interest from Google Trend

Above is snippet of Google Trends for "cyxone AB" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Cyxone, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.